Cancer

(001) A Novel Methodology for Assessing Response to Lymphoma Treatment using Real World Data – the Real-World Lugano (rwLugano) Study

(002) A Quantitative Bias Analysis to Assess the Impact of Tumor Selection on Linear Growth in Observational Research: a Case Study in Renal Cancer.

(003) Age and sex-specific incidence of fracture events among persons with chronic lymphocytic leukemia

(004) Antidepressant use and depressive symptoms in cancer survivors: a Danish population-based study

(005) Assessment of the potential risk of seizure among patients with prostate cancer treated with enzalutamide in China: a non-interventional study

(007) Beyond external control arms: utility of real-world data in oncology regulatory applications

(008) Breast cancer incidence by subtypes - a Danish register-based study from 2012 to 2022.

(009) Breast cancer recurrence due to avoidable drug-drug interactions? Developing a protocol for a target trial in women with breast cancer who concurrently use tamoxifen and antidepressants

(010) Cardiotoxic Cancer Treatment in Screen-Detected Versus Non-Screen-Detected Breast Cancer Patients: A Study Based on German Claims Data

(011) Characteristics and treatment sequences of patients with KRAS G12C, other KRAS and KRAS-wild-type advanced or metastatic (AM) Non-Small Cell Lung Cancer (NSCLC) in the French ESME cohort

(012) Characterization of Novel Longitudinal Oncology Real World Datasets in Germany and UK

(013) Clinical Features Associated with Disease Response Classification in Lymphoma: A Comparison of Data from Manual Chart Review and Blinded Independent Central Review

(014) Current Trends in the Therapeutic Management of Metastatic Prostate Cancer in Clinical Practice

(015) Discordance between clinical and pathological stage in non-small cell lung cancer patients in China

(016) Empirical Estimation of Hepatocellular Carcinoma Prevalence in Saudi Arabia: A Gender and Age Group Analysis

(017) Feasibility of Using Deidentified Positron Emission Tomography–Computed Tomography (PET-CT) Scans to Support a Blinded Independent Central Review for Lymphoma Treatment Response Assessment using Real-World Data

(019) Incidence, Treatment Pattern, and Implications of Chemotherapy-Related Anemia in Patients with Solid Tumors in China: A Multicenter Retrospective Cohort Study

(020) Incremental Burden of Comorbidity on Health-Related Quality of Life in Patients with Prostate Cancer

(021) Ischemic Cardiotoxicity of Aromatase Inhibitors in Postmenopausal Women with Early Breast Cancer: an Analysis of Real-World Data

(023) Neutropenia among patients with prostate cancer: Analysis of four US real world databases

(024) Performance of ChatGPT-3.5, ChatGPT-4, Microsoft Copilot, and Google Bard To Identify Correct Information for Lung Cancer

(025) Phenotype Development and Characterization of Patients with Prostate Cancer in Varying Disease Phases Using Real-World Data

(026) Real-world effectiveness of oral novel hormonal agents in patients with advanced prostate cancer: a head-to-head comparison using longitudinal, territory-wide electronic medical records

(027) Representativeness of race, ethnicity and social determinants of health in patients with advanced non-small cell lung cancer via linkage of real-world electronic health records, administrative claims, and consumer financial data

(028) Results from an analysis of data from the US SEER registries to estimate the prevalence of gastroenteropancreatic neuroendocrine tumors in the US, in the context of limited available evidence for regulatory discussions

(029) Risk factors for malignant transformation of oral epithelial dysplasia: a systematic review and meta-regression analysis

(030) The impact of Body Mass Index on colorectal cancer prognosis. A population-based cohort study in Denmark.

(031) The relation between tamoxifen metabolism and time to discontinuation: A Bayesian pathway analysis in premenopausal breast cancer patients

(032) Update on malignant transformation rate of oral epithelial dysplasia: a systematic review.

(033) US and Global Cutaneous Melanoma Burden: An Updated Epidemiology Assessment

(034) Vascular Endothelial Growth Factor Pathway Inhibitors and the Risk of Aortic Aneurysm and Aortic Dissection: A Nested Case-Control Study

(046) Adverse Effects of Tyrosine Kinase Inhibitors on Glucose and Lipid Metabolism in Patients with Chronic Myeloid Leukemia

(047) Anaphylaxis Risk and Long-Term Central Venous Catheter Use: a Health Plan Claims Database Analysis Comparing Subcutaneous and Intravenous Pertuzumab / Trastuzumab Administration in the US

(048) Antiangiogenic Drugs and the Risk of Arterial Dissection or Aneurysm in Patients with Metastatic Colorectal Cancer

(049) Assess the applicability of capmatinib and tepotinib to real-world patients in Taiwan with MET mutations

(050) Association Between Aromatase Inhibitors and Dry Eye Disease Among Women with Breast Cancer

(052) Clinical Responses to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Patient Characteristics and Predictors

(053) Comparative Analysis on incident risk of Anemia and Immune-Mediated Hepatitis in non-small cell lung cancer (NSCLC): Enhancing Cross-Data Source Comparability in PD-1/PD-L1 Therapy

(055) Development and portability of a text mining algorithm for capturing disease progression in electronic health records of with stage IV non-small cell lung cancer treated with immuno-chemotherapy

(056) Examination of treatment patterns amongst drug classes in metastatic non-small cell lung cancer patients across EU4, UK, and US

(059) Fluoropyrimidine chemotherapy and the risk of death and cardiovascular events in patients with gastrointestinal cancer: a cohort study

(060) Genomic profiling and the need for immunotherapy in gastric cancer

(061) Healthcare Utilization among Cancer Patients Treated with Immune Checkpoint Inhibitors in Taiwan

(062) Identifying Adverse Drug Reactions Through Knowledge Graph Modeling

(063) Identifying the Period of Heightened Risk for Adrenal Insufficiency in Patients with Advanced Non-Small Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors

(064) Incidence and risk of secondary myelodysplastic syndrome and acute myeloid leukaemia in ovarian cancer patients treated with poly-ADP ribose polymerase inhibitors in England

(066) Incidence of Infections in Clinical Trials of Treatments for Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-Analysis

(068) Investigating the Effect of Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Radiotherapy-related Toxicities and Treatment Outcome in Patients with Cancer: A Systematic Review and Meta-Analysis

(070) NALIRIFOX versus FOLFOX as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall (OS) survival analysis

(071) Ocular adverse events associated with platins: A disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports

(072) Patterns of Underreporting of Enrollment Dates in Cancer Clinical Trials: A HemOnc Knowledgebase Analysis

(073) Pharmacometaboomics suggest a causal link between an excipient in cyclosporine A capsules and incomplete mycophenolate mofetil prodrug activation in kidney transplant recipients

(074) Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in Advanced Non-Small Cell Lung Cancer (aNSCLC): Analysis of Patient-Level Pooled Randomized Clinical Trials (RCTs)

(075) Real-World Treatment of Patients with Chronic Lymphocytic Leukemia: Results from Analysis of US Health Insurance Claims Dataset

(076) Real-World utilization of 1L systemic therapy amongst Black and Non-Hispanic White patients with advanced or recurrent endometrial cancer

(077) Replication of overall response in mNSCLC patients treated with pembrolizumab and chemotherapy using RECIST 1.1 criteria applied to images from the real world

(078) Risk Evaluation of Vascular Adverse Events in Chronic Myeloid Leukemia Patients Following First-Line TKI Therapy Initiation

(079) Synthesized Learnings and Considerations from Global Historical Cohort Studies via Retrospective Chart Review in Oncology

(080) The treatment modalities and radiotherapy pattern in patients of primary lung cancer with distant metastasis in Japan

(081) The use of opioid and non-opioid analgesics and illicit drugs among patients with cancer in the U.S.: prevalence and association with mortality

(082) Use of Systemic and Topical Glucocorticoids and Risk of Skin Cancers in a Prospective Cohort of French Women.

(083) Utility of Digitally-Enabled Tools in Community Education and Activation for LDCT screening for Lung Cancer